An Evaluation of a Universal Funding Program for Pediatric Insulin Pumps in Ontario
|
|
- Chad Douglas
- 6 years ago
- Views:
Transcription
1 An Evaluation of a Universal Funding Program for Pediatric Insulin Pumps in Ontario McMaster Endocrinology Rounds September 16, 2016 Rayzel Shulman MD, PhD, FRCPC
2 German/Austrian Prospective Diabetes Follow-up Registry (DPV) (n=26,198) % on pump 41 T1D Exchange (n=13,755) 47 Patterns of pump use English/Welsh National Paediatric Diabetes Audit (NPDA) (n=14,457) 14 SWEET multicentre registry (n= ) 44.4 Szypowska et al. Pediatric Diabetes 2016 Sherr et al. Diabetologia 2016
3 Sweden: n 5000 T1D DKA twice as high in pump vs. injections 77% within first year after pump start Pump Safety Australia: n=345 on pump DKA rate in pump vs. injection 2.3 vs. 4.7/100 person-years Newfoundland: n=90 DKA admissions 70% use pump DKA with established diabetes, 23.6% failed to recognize pump problem Hanas et al. Pediatric Diabetes 2009 Jackman et al. BMC Research Notes 2015 Johnson et al. Diabetic Medicine 2013
4 Glycemic control Systematic Review RCTs CSII vs. MDI HbA1c was reduced by 0.32 % in children (95 % CI, ) P = Benkhadra K et al. Endocrine 2016 Improvement during first year then back toward baseline beyond 1 yr- review Shulman R et al. Diabetes Management 2012
5 The Policy Problem Equivocal evidence about comparative long-term effectiveness Marginal benefits at increased costs ($2,000 USD annually) Ontario: universal funding since 2006 Lee et al. Journal of Pediatrics 2015; 167 (2):
6 Objectives Appreciate the Ontario context for pediatric insulin pump therapy Describe patterns of pediatric pump use in Ontario Examine factors associated with the safety profile of pump therapy in Ontario Understand how pumps are valued by physicians
7 Populationbased health administrative data Pediatric Diabetes Survey data about centres characteristics and resources Physician interviews about experience using pump therapy
8 Not-for-profit research institute Community of research, data and clinical experts Secure and accessible Ontario healthrelated data Admissions, ED visits, outpatient visits, lab data Population and Demographic data Links to PCMCH and MOH
9 Shulman et al. CMAJ Open 2016 Ontario Pediatric Diabetes Network Current State Survey 2013
10
11
12
13 Network description: Main Findings and Contribution Caseload of diabetes nurses varies across centres Differences in availability of 24 hour support Set the stage to examine relationship of local resources and pump use and safety
14
15 Methods Brought in ADP pump data to ICES Pump cohort Approved initial ADP application for pediatric pump November 1, March 31, 2013 Non-pump cohort (for baseline comparison) <19th birthday, prevalent in ODD on January 1, 2008, exclude pump users
16 Methods Association between uptake (centrelevel) and 24 hr support Negative binomial model Association between discontinuation (patient-level) and: Socioeconomic status Mean A1c before pump start Cox proportional hazards model with generalized estimating equations (GEE) to account for clustering at centres
17
18 Pump Use Following the Introduction of a Universal Funding Program in % ( %) Number of individuals on pump therapy as of Jan 1 of each year Number of new applications in each calendar year (2007 includes Nov- Dec 2006 and 2012 includes Jan-Mar 2013)
19
20 Pump Uptake
21 Discontinuation 51 individuals discontinued pump therapy Discontinuation rate: 0.42 per 100 person-years
22
23 Pump use: Main Findings Pump cohort less deprived than nonpump cohort Universal funding: pump use is high and discontinuation very low Large variation in pump use not explained by the centre-level factors Discontinuation associated with small community centres and low SES
24 Pump Use: Limitations Pump uptake only measurable in 2012 We measured applications for pump funding, not actual pump use Date of discontinuation was estimated
25 Pump use: Discussion Disparity in pump use by SES Financial barriers Physician attitudes Need to further characterise population and practice patterns Design interventions aimed at improving appropriate access to and outcomes
26 Adverse Events in pump users
27 March 31, year baseline period Follow-up period Pump cohort n=3193 Initial application (Nov Mar 31, 2011) <19 th birthday
28 Outcomes and Exposures Primary Outcome: First admission for DKA or death Secondary Outcome: Diabetes-related admissions and ED visits Exposures: Socioeconomic status (SES) Low SES associated with increased risk of DKA 24 hour support DKA prevention programs including 24 hr support associated with decreased risk of DKA Keenan et al. Pediatrics (2002) 109(1) Hoffman WH et al. Diabetes Care (1978) 1
29 Results Rate of DKA was 5.28 per 100 personyears Baseline rate of DKA was 6.97 per 100 person-years Mean age at the time of first DKA admission or death was 12.8 years (SD 3.8) There were <6 deaths
30 Event free probability Cumulative Probability of DKA or death according to time since pump start Months since pump start
31
32
33 Safety Profile: Main Findings In the context of universal funding: positive safety profile that is not related to access to 24 hour support Lower income children had both a higher risk of DKA and diabetes-related admissions and ED visits. Identified other factor associated with increased risk of adverse events: Higher HbA1c Older age Prior DKA Higher nursing patient load
34 Safety Profile: Limitations Deprivation index is an ecologic measure but likely good proxy for individual SES Nursing patient ratio may be incomplete Could not measure A1c as an outcome
35 Safety Profile: Discussion Underlying causes of SES disparities requires further investigation High risk groups identified Need better understanding of nuances of centre-specific approaches to pump therapy
36
37 Physicians role Physicians beliefs about technology and the populations that they serve influence adoption processes Understanding how physicians, who play a critical role in adoption processes, value this technology is critical to understanding patterns of adoption
38 Objective and Importance To characterize physicians perceptions of how pumps are valued Understanding physicians valuation rationales is critical to: Inform policy and funding decisions that encourage more appropriate patterns of adoption Assist providers by encouraging more appropriate and successful use of technology in their practice
39 Methods Open-ended semi-structured interviews 16 physicians from Ontario PDN Qualitative descriptive approach Memos to group data by descriptive patterns based on pre-structured themes Iterative process Final themes based on different ways of valuing pump therapy
40
41 Results Theme 1: Falling Short Potential for good glycemic control, but most users do not do the hard work required Reliance on support from a broad network of care
42 Theme 1: Falling short people go on a pump thinking now they can eat whatever they want to eat; all they have to do is carbohydrate count and appropriately change their insulin doses and things will be fine. But, I think most people s abilities to actually carbohydrate count aren t that precise or accurate. They forget sometimes to give themselves extra boluses. And, so, that increased flexibility, if not fully accommodated, can actually result in worse control in the end or maybe a reason why some of these increased technologies haven t resulted in the improved outcomes we had hoped for (academic specialist-6)
43 Theme 2: Valuing Technology Valuing Technology Status as new technologies, with inherent appeal as the best way to manage diabetes Promise of future technology we need to be embracing the technology and encouraging them to be developing new and better tools. (academic specialist-16).
44 Theme 3: Building Therapeutic Relationships Building Therapeutic Relationships Enduring relationship with a child with a chronic illness and their family Tools to engage and motivate Respondents perceived that parents whose children they cared for want their child to have a more normal life and be more like their friends (academic specialist-5)
45 Limitations Unable to measure the value of pediatric insulin pump therapy, rather how it is valued by physicians Even if physicians perceptions about pumps are valued are inaccurate, they govern behaviour and help to explain the dynamics of adoption Did not study other key players
46 Conclusions Widespread use not a misunderstanding about effectiveness Technology is costly and excessive enthusiasm may eclipse a more thoughtful process of adoption Clinicians should consider how the therapeutic relationship, mediated by the role of pumps/other technology, may be influencing diabetes outcomes Policy makers and clinicians will have to consider how new tech is valued and decide whether and how to adopt them into practice and the healthcare system.
47 Need to better understand the dynamics of practice variation and the underlying causes of disparity and outcomes. Future Directions Evaluation of diabetes care using multiple methods to understand: practice patterns clinical outcomes practice goals and expectations of providers and patients and families
48 Acknowledgments CCHCSP Doctoral Award/Department of Pediatrics Creative Professional Activities grant from the Hospital for Sick Children and CIHR Applied Chair in Child Health Services and Policy Research (A Guttmann) Supervisors, mentors, committee members Astrid Guttmann Fiona Miller Denis Daneman Therese Stukel Alice Newman (data analyst) Division of Endocrinology, The Hospital for Sick Children
49 Questions
50 Only 66% of pump users assigned to their centre correctly using their postal code Validation of assignment to centre by postal code Not correctly assigned Correctly assigned Community 501 (52.0%) 1,349 (72.3%) Tertiary 462 (48.0%) 517 (27.7%)
51 SWEET: n= Glycemic control When adjustment for age, gender, and diabetes duration: A1c in CSII remains lower than MDI
Rayzel Shulman MD, PhD CAHSPR May 10, 2016
+ Low Socioeconomic Status is Associated with Adverse Events in Children and Teens on Insulin Pumps Under a Universal Access Program: A population-based Cohort Study Rayzel Shulman MD, PhD CAHSPR May 10,
More informationResources and population served: a description of the Ontario Paediatric Diabetes Network
Resources and population served: a description of the Ontario Paediatric Diabetes Network CMAJ OPEN Rayzel Shulman MD, Fiona A. Miller PhD, Therese A. Stukel PhD, Denis Daneman MBBCh DSc(Med), Astrid Guttmann
More informationDiabetes Management in Toddlers/Preschoolers (<6 yo)
Diabetes Management in Toddlers/Preschoolers (
More informationAudit support for continuous subcutaneous insulin infusion for the treatment of diabetes mellitus (review of technology appraisal guidance 57)
Audit support for continuous subcutaneous insulin (review of technology appraisal guidance 57) Issue date: 2008 Audit support Continuous subcutaneous insulin infusion for the treatment of diabetes mellitus
More informationCLINICAL UTILITY OF CONTINUOUS SUBCUTANEOUS INSULIN INFUSION IN PATIENTS WITH TYPE 1 DIABETES: A MACEDONIAN REPORT
University Department of Endocrinology, Diabetes and Metabolic Disorders, Medical Faculty, Sv. Kiril I Metodij University, Skopje, Macedonia Scientific Paper Received: February 19, 2007 Accepted: March
More informationResearch Article Measures of Adherence and Challenges in Using Glucometer Data in Youth with Type 1 Diabetes: Rethinking the Value of Self-Report
Hindawi Diabetes Research Volume 2017, Article ID 1075428, 4 pages https://doi.org/10.1155/2017/1075428 Research Article Measures of Adherence and Challenges in Using Glucometer Data in Youth with Type
More informationThe Diamond Study: Continuous Glucose Monitoring In Patients on Mulitple Daily Insulin Injections
8/5/217 The Diamond Study: Continuous Glucose Monitoring In Patients on Mulitple Daily Insulin Injections Richard M. Bergenstal, MD Executive Director International Diabetes Center at Park Nicollet Minneapolis,
More informationSandwell & West Birmingham integrated community care diabetes model (DICE) the future of diabetes services?
Sandwell & West Birmingham integrated community care diabetes model (DICE) the future of diabetes services? Dr PARIJAT DE DUK Clinical Champion Clinical Lead for Diabetes & Endocrinology, Sandwell & West
More informationDAFNE (Dose Adjustment For Normal Eating)
DAFNE (Dose Adjustment For Normal Eating) Promoting the Expert Patient Professor David McIntyre Mater Health Services and University of Queensland Brisbane AUSTRALIA DAFNE and OzDAFNE Outline Context of
More informationPREVENTION OF NOCTURNAL HYPOGLYCEMIA USING PREDICTIVE LOW GLUCOSE SUSPEND (PLGS)
PREVENTION OF NOCTURNAL HYPOGLYCEMIA USING PREDICTIVE LOW GLUCOSE SUSPEND (PLGS) Pathways for Future Treatment and Management of Diabetes H. Peter Chase, MD Carousel of Hope Symposium Beverly Hilton, Beverly
More informationThe National Paediatric Diabetes Audit
Introduction The National Paediatric Diabetes Audit (NPDA) for and is commissioned by the Healthcare Quality Improvement Partnership (HQIP) as part of the National Clinical Audit and Patient Outcomes Programme
More informationThe Ontario Drug Policy Research Network: Generating Evidence to Inform Policy
The Ontario Drug Policy Research Network: Generating Evidence to Inform Policy Presented by Tara Gomes The Ontario Drug Policy Research Network April 20, 2010 1 Overview Integrating Research into Drug
More informationNational Paediatric Diabetes Audit
National Paediatric Diabetes Audit Parent and Carers Report 2015-16 Commissioned by the Healthcare Quality Improvement Partnership Managed by the Royal College of Paediatrics and Child Health National
More informationHOW CAN WE PREVENT RECURRENT-DKA?
pinterest HOW CAN WE PREVENT RECURRENT-DKA? Birgit Rami-Merhar DKA is not only a problem at the onset of T1D T1D-children at risk for recurrent DKA: 1-10%/patient/year (ISPAD 2014) mortality rate from
More informationArt Lift, Gloucestershire. Evaluation Report: Executive Summary
Art Lift, Gloucestershire Evaluation Report: Executive Summary University of Gloucestershire September 2011 Evaluation Team: Dr Diane Crone (Lead), Elaine O Connell (Research Student), Professor David
More informationNational Diabetes Insulin Pump Audit, England and Wales
National Diabetes Insulin Pump Audit, 2016-2017 England and Wales V0.22 7 March 2017 Prepared in collaboration with: The Healthcare Quality Improvement Partnership (HQIP). The National Diabetes Audit (NDA)
More informationExamples of Reflection / Learning Outcomes
Examples of Clinician Reflection Now responding to patient s blood glucose record more respectfully and asking patient for permission before giving advice. Helping client to brainstorm their own solutions
More informationUnderstanding patient experience of diabetes in London: Identifying what s needed to support those living and coping with diabetes
Understanding patient experience of diabetes in London: Identifying what s needed to support those living and coping with diabetes Author: Paul Trevatt, Lead London Diabetes Strategic Clinical Network
More informationIn Numbers a statistical overview of the NOMS Co-financing Organisation. South East Round 1: Custody & Community
In Numbers a statistical overview of the NOMS Co-financing Organisation 1. Introduction NOMS Co-financing Organisation Since 2010, the ESF (European Social Fund) funded NOMS Cofinancing programme has been
More informationLeah M Smith, Jay S Kaufman, Erin C Strumpf, Linda E Lévesque
The effect of HPV vaccination on clinical indicators of sexual behaviour in a population-based cohort of adolescent girls: The Ontario Grade 8 HPV Vaccine Cohort Study Leah M Smith, Jay S Kaufman, Erin
More informationDiabetes, Ketone testing in Type 1 Diabetes
CLINICAL GUIDELINE Diabetes, Ketone testing in Type 1 Diabetes A guideline is intended to assist healthcare professionals in the choice of disease-specific treatments. Clinical judgement should be exercised
More informationPatterns and Cost of Health Care Transitions to Adult Care among Youth with Chronic Conditions in Ontario: A Population Based Cohort Study
Patterns and Cost of Health Care Transitions to Adult Care among Youth with Chronic Conditions in Ontario: A Population Based Cohort Study Eyal Cohen, MD, MSc; Sima Gandhi, MSc; Charlotte Moore, MD; Alene
More informationPersonal statement on Continuous Subcutaneous Insulin Infusion Professor John Pickup
1 Personal statement on Continuous Subcutaneous Insulin Infusion Professor John Pickup King s College London School of Medicine, Guy s Hospital, London SE1 9RT Experience of the technology I am the lead
More informationLessons From The Type 1 Diabetes Exchange
Lessons From The Type 1 Diabetes Exchange Andrew Ahmann, MD Harold Schnitzer Diabetes Health Center at OHSU Presenter Disclosure Information In compliance with the accrediting board policies, the American
More informationImplementing the ASSIST smoking prevention programme following a successful RCT. Rona Campbell
Implementing the ASSIST smoking prevention programme following a successful RCT Rona Campbell DECIPHer Development and Evaluation of Complex Interventions for Public Health Improvement Aim Review issues
More informationIn Numbers a statistical overview of the NOMS Co-financing Organisation. East of England Round 1: Custody & Community
In Numbers a statistical overview of the NOMS Co-financing Organisation 1. Introduction NOMS Co-financing Organisation Since 2010, the ESF (European Social Fund) funded NOMS Cofinancing programme has been
More informationIn Numbers a statistical overview of the NOMS Co-financing Organisation. South West Round 1: Community
In Numbers a statistical overview of the NOMS Co-financing Organisation 1. Introduction NOMS Co-financing Organisation Since 2010, the ESF (European Social Fund) funded NOMS Cofinancing programme has been
More informationExecutive Summary Management of Type 1 Diabetes Mellitus during illness in children and young people under 18 years (Sick Day Rules)
Executive Summary Management of Type 1 Diabetes Mellitus during illness in children and young people under 18 years (Sick Day Rules) SETTING FOR STAFF PATIENTS Medical and nursing staff Children and young
More informationInsulin pump evaluation
Insulin pump evaluation Mike Jensen, who lives in New Zealand, discusses his experience of using an insulin pump for a trial period of three weeks Sleep I experienced a significantly better quality of
More informationThe impact of health information exchange
The impact of health information exchange Joshua R Vest, PhD, MPH Associate Professor Department of Health Policy & Management Richard M. Fairbanks School of Public Health Indiana University Indianapolis
More informationABSTRACT BOOK All in all Diabetes management as a joint task
ABSTRACT BOOK All in all Diabetes management as a joint task ISPAD 2016 2017 Breakfast Symposium Valencia, Innsbruck, Spain Austria Thursday, October 27, 19, 2016 2017 Welcome to Innsbruck welcome to the
More informationCOPYRIGHTED MATERIAL. Chapter 1 An Introduction to Insulin Pump Therapy WHAT IS INSULIN PUMP THERAPY?
Chapter 1 An Introduction to Insulin Pump Therapy This chapter will provide information on what insulin pump therapy is, and how insulin pumps have developed from the early models introduced in the 1970s
More informationCGM: Continuous Glucose Monitoring Making Sense of It All AW: ANCO/GEND/1016/0117
CGM: Continuous Glucose Monitoring Making Sense of It All Objectives Review how to do a time effective interpretation of CGM and insulin pump download data Review how medications, lifestyle, and current
More information8/8/2015. The Educational Needs of Fathers of Youth with Diabetes: A Mixed Methods Study. Diabetes Management
Anastasia Albanese-O Neill PhD, ARNP, CDE Assistant Professor University of Florida, College of Nursing Gainesville, FL Disclosure to Participants Notice of Requirements For Successful Completion Please
More informationAn Evaluation of the Barriers to Patient use of Glucometer Control Solutions: A Survey of Patients, Pharmacists, and Providers
AADE14 ANNUAL MEETING & EXHIBITION AUGUST 6-9, 2014 ORLANDO, FL An Evaluation of the Barriers to Patient use of Glucometer s: A Survey of Patients, Pharmacists, and Providers Katherine S. O Neal, Pharm.D.,
More informationPolicy for the Provision of Insulin Pumps for Patients with Diabetes Mellitus
Policy for the Provision of Insulin Pumps for Patients with Diabetes Mellitus Version No. Changes Made Version of July 2018 V0.5 Changes made to the policy following patient engagement including: - the
More informationPage 1 of 6. Health Economics Group Module 5 Examples & getting projects funded. Designing Economic Evaluation Alongside Clinical Studies
Designing Economic Evaluation Alongside Clinical Studies Health Economics Short Course For more information and course dates, please visit our website http://mdhs-study.unimelb.edu.au/short-courses/mspghshort-courses/designing-economic-evaluation-alongsideclinical-studies/overview
More information(Making) Shared Decision Making Part of Usual Care
N N E A C C N O R T H E R N N E W E N G L A N D A C C O U N T A B L E C A R E C O L L A B O R A T I V E (Making) Shared Decision Making Part of Usual Care Healthy Dialogues August 26, 2014 David E Wennberg,
More informationUser Experience: Findings from Patient Telehealth Survey
User Experience: Findings from Patient Telehealth Survey Sarah Gorst University of Sheffield NIHR CLAHRC for South Yorkshire MALT WS3: User experience Overcoming the Barriers to Mainstreaming Assisted
More information15 th Annual DAFNE collaborative meeting Tuesday 28 th June 2016
15 th Annual DAFNE collaborative meeting Tuesday 28 th June 2016 Sponsored by: Abbott Diabetes Care and Lilly Diabetes The REPOSE Trial (Relative Effectiveness of Pumps over Structured Education) Background
More informationMultimedia Appendix 1. Treatment and disease management Overview of papers mhealth articles
Multimedia Appendix 1. Treatment and disease management Overview of papers mhealth articles Research Country and Sampl e size Device Aims Key effects reference USA [1] 8 Voice To evaluate the practicality
More informationManaging obesity in primary health care Mark Harris
Managing obesity in primary health care Mark Harris COMPaRE-PHC is funded by the Australian Primary Health Care Research Institute, which is supported by a grant from the Commonwealth of Australia as represented
More informationPeople living with type 1 diabetes face a. Barriers to improving glycaemic control in CSII. Joan Everett, Anita Bowes, David Kerr
Barriers to improving glycaemic control in CSII Article points 1. Focus groups were conducted to determine why some people with type 1 diabetes using continuous subcutaneous insulin infusion (CSII) maintain
More informationCounting the Carbs, Fat and Protein in Type 1 Diabetes Translating the Research into Clinical Practice
Welcome to Allied Health Telehealth Virtual Education Counting the Carbs, Fats and Protein in Type 1 Diabetes Translating the Research into Clinical Practice Dr Carmel Smart, PhD Senior Specialist Paediatric
More informationCost and Consequence: Trying to balance affordability and adherence
Cost and Consequence: Trying to balance affordability and adherence A James 1, J Hunleth 1, S Smith, 1 K Gilbert 2, D Bowen 3 1 Washington University in St Louis, 2 St Louis University, 3 University of
More informationDementia and Diabetes
Dementia and Diabetes Dr Jill Rasmussen RCGP Clinical Representative Dementia, jill.rasmussen@psi-napse.com 1 Dementia and Diabetes - Overview The Facts Implications for the Well Pathway Mild Cognitive
More informationNew Clinical Solutions in Diabetes Care
Welcome to the Lakeside Conference Centre and the New Clinical Solutions Conference 2011 A collaboration: Worldwide 346 million people have diabetes World Health Organisation In 2010 the estimated prevalence
More informationSpinal Cord Injury Research. By the Department of Clinical Psychology, National Spinal Injuries Centre
Stoke Mandeville Hospital Spinal Cord Injury Research By the Department of Clinical Psychology, National Spinal Injuries Centre 2008-2009 Department of Clinical Psychology, National Spinal Injuries Centre,
More informationCalgary Diabetes Centre Insulin Pump Therapy: Preparation and Expectations
Calgary Diabetes Centre Insulin Pump Therapy: Preparation and Expectations This is a long and important document. It lists the steps for starting insulin pump therapy at the Calgary Diabetes Centre. It
More informationCASE STUDY: Measles Mumps & Rubella vaccination. Health Equity Audit
CASE STUDY: Measles Mumps & Rubella vaccination Health Equity Audit October 2007 Dr Marie-Noelle Vieu Public Health - Lambeth PCT 1 Contents 1. Executive summary page: Lambeth PCT MMR vaccination Equity
More informationCase-finding for Hepatitis C in Primary Care
Case-finding for Hepatitis C in Primary Care Dr Shivani Datta, Academic FY2 Supervisors: Professor Matthew Hickman, Dr Jeremy Horwood & Professor Debbie Sharp School of Social and Community Medicine, University
More informationEuropean Perspective on Paediatric Diabetes Care
Keystone, Colorado, July 2013 Practical Ways to Achieve Targets in Diabetes Care European Perspective on Paediatric Diabetes Care Professor David Dunger Department of Paediatrics Practical Ways to Achieve
More informationEndocrinology: Patient Noncompliance vs. Provider Bias: A Clinical Revelation
Endocrinology: Patient Noncompliance vs. Provider Bias: A Clinical Revelation Pamela Combs, MSN, BC-ANP, CDE 1 Case Study: Bobbi This is a case regarding a patient who presented to the Cleveland Clinic
More informationEvaluation of Pump Discontinuation and Associated Factors in the T1D Exchange Clinic Registry
663963DSTXXX10.1177/1932296816663963Journal of Diabetes Science and TechnologyWong et al research-article2016 Original Article Evaluation of Pump Discontinuation and Associated Factors in the T1D Exchange
More information10 myths about type 2 diabetes By Anne Bokma
10 myths about type 2 diabetes By Anne Bokma While people with type 2 diabetes need to learn everything they can about their condition in order to manage it as best they can, sometimes they also need to
More informationTechnological advances have led to innovative insulin delivery systems for patients with type 1 diabetes mellitus. In particular,
A Retrospective Review of the Clinical Characteristics and Blood Glucose Data from Cellnovo System Users using Data Collected from the Cellnovo Online Platform Olivia Hautier-Suply, Yasmin Friedmann and
More informationPublished online October 23,
Author, year (country) Agurs- Collins, 43 1997 (USA) n (completing), mean age, % male, other characteristics 64 (55), 61 7years, 33% male, All >55 years, African American Recruitment Follow-up Description
More informationSmoke and mirrors: where is the K for KT? Jeremy Grimshaw MD, PhD
Smoke and mirrors: where is the K for KT? Jeremy Grimshaw MD, PhD Clinical Epidemiology Program, OHRI Department of Medicine, University of Ottawa Canada Research Chair in Health Knowledge Transfer and
More informationTreatment guideline for adult patients with type 1 diabetes?
Treatment guideline for adult patients with type 1 diabetes? Jae Hyeon Kim Division of Endocrinology and Metabolism, Samsung Medical Center, Sungkyunkwan University School of Medicine ICDM 2014 Treatment
More informationIntegrative Medicine Group Visits: A New Model of Care for Managing Health and Well-Being Katherine Gergen Barnett, MD Diane Rogers June 25, 2015
+ Integrative Medicine Group Visits: A New Model of Care for Managing Health and Well-Being Katherine Gergen Barnett, MD Diane Rogers June 25, 2015 Safety net hospital for Boston and surrounding communities;
More informationAdherence to therapy. Kamlesh Khunti University of Leicester, UK. William Polonsky University of California San Diego, USA
Adherence to therapy Kamlesh Khunti University of Leicester, UK William Polonsky University of California San Diego, USA 1 Dualities of interest Kamlesh Khunti: Honoraria for speaking, advising or research
More informationAwareness and understanding of dementia in New Zealand
Awareness and understanding of dementia in New Zealand Alzheimers NZ Telephone survey May 2017 Contents Contents... 2 Key findings... 3 Executive summary... 5 1 Methodology... 8 1.1 Background and objectives...
More informationThe Importance of Communication in the Construction of Partial Dentures Br Dent J 2018; 224(11):
Using Patients as Educators for Communication Skills: Exploring Dental Students and Patients Views Student Perspectives on Using Egocentric Video Recorded by Smart Glasses to Assess Communicative and Clinical
More informationAna M. Artiles, RN, CDE and Margo Small MSW, RSW. Diabetes Team SickKids
Ana M. Artiles, RN, CDE and Margo Small MSW, RSW. Diabetes Team SickKids Objectives To understand the concept of transition in adolescent health care delivery To appreciate how transition impacts diabetes
More informationWhat is a CGM? (Continuous Glucose Monitor) The Bionic Pancreas Is Coming
The Bionic Pancreas Is Coming Montana Diabetes Professional Conference October 23, 2014 H. Peter Chase, MD Professor of Pediatrics University of Colorado Barbara Davis Center Stanford: Bruce Buckingham,
More informationTRANSITION FROM PAEDIATRIC TO ADULT CARE. Dr Mary White Paediatric Endocrinologist
TRANSITION FROM PAEDIATRIC TO ADULT CARE Dr Mary White Paediatric Endocrinologist Outline Background What happens to paediatric patients posttransition? Glycaemic control and complications Clinic attendance
More informationWhat is the role of insulin pumps in the modern day care of patients with Type 1 diabetes?
What is the role of insulin pumps in the modern day care of patients with Type 1 diabetes? Dr. Fiona Wotherspoon Consultant in Diabetes and Endocrinology Dorset County Hospital Fiona.Wotherspoon@dchft.nhs.uk
More informationMental health and Deafness: Interpreters perspectives on compassion and the development of the therapeutic alliance.
1 Thesis Presentation Mental health and Deafness: Interpreters perspectives on compassion and the development of the therapeutic alliance. LAURA CATHERINE WEDLOCK 2014 COHORT Aims of this presentation
More informationThe Autism Families Research Study: Siblings of Children with ASD. Research Summary Report
Siblings of children with ASD 1 The Autism Families Research Study: Siblings of Children with ASD Research Summary Report Prepared for NAS Cymru by Michael Petalas, Professor Richard Hastings, Dr Susie
More informationA Preliminary Evaluation of the KidneyWise Clinical Toolkit For Primary Care
A Preliminary Evaluation of the KidneyWise Clinical Toolkit For Primary Care Allan Grill MD, CCFP, MPH, FCFP, CCPE Provincial Primary Care Lead, Ontario Renal Network & Lead Physician, Markham Family Health
More informationWhen Will CGM Replace SMBG? Roy W. Beck, MD, PhD. JAEB Center for Health Research Tampa, Florida
When Will CGM Replace SMBG? Roy W. Beck, MD, PhD JAEB Center for Health Research Tampa, Florida Financial Disclosures Dr. Beck does not have any personal conflicts of interest His employer, the JAEB Center
More informationDr Dan Grabowski Steno Diabetes Centre
Dr Dan Grabowski Steno Diabetes Centre Barriers to intra-familial prevention of type 2 diabetes: A qualitative study on horizons of significance and social imaginaries. Dan Grabowski, PhD Sociologist,
More informationDialectical Behaviour Therapy in Secure Services Calverton Hill & Priory Hospital East Midlands Priory Group
Context Our Dialectical Behaviour Therapy (DBT) team is a large multi-site team offering a standard DBT programme to patients who present with complex, severe, and enduring mental illness, personality
More informationInsulin Pump Therapy in children. Prof. Abdulmoein Al-Agha, FRCPCH(UK)
Insulin Pump Therapy in children Prof. Abdulmoein Al-Agha, FRCPCH(UK) aagha@kau.edu.sa Highlights Evolution of insulin pump Pumps mimics Pancreas Goals of diabetes care What lowers HbA1c Criteria for selection
More informationNHS Leeds CCG. Policy for the Funding of Flash Glucose Monitoring (FlashGM) in Paediatrics and Adults
NHS Leeds CCG Policy for the Funding of Flash Glucose Monitoring (FlashGM) in Paediatrics and Adults Produced by: Jo Alldred, Medicines Effectiveness Lead, NHS Leeds CCG Dr Bryan Power, Long Term Conditions
More informationEpidemiological and survey research to characterize multi-level factors associated with HPV vaccination rates
Epidemiological and survey research to characterize multi-level factors associated with HPV vaccination rates Finney Rutten LJ, Radecki Breitkopf C, Jacobson RM Mayo Clinic, Rochester, MN 20Reminder/Recall7
More informationfor the Management of Chronic Disease
Patient-Centred Care Approaches for the Management of Chronic Disease Anna Chapman Research Fellow RDNS Institute Overview of Presentation Burden Second of level Disease in Australia Chronic Disease Management
More informationRole of the Clinical Pharmacist in Primary Care
Role of the Clinical Pharmacist in Primary Care Amy Kramer, Pharm.D., Manager Clinical Pharmacy Services Kaiser Permanente Holly Miller, Pharm.D., BCACP, Primary Care Clinical Pharmacist Kaiser Permanente
More informationPEER REVIEW HISTORY ARTICLE DETAILS TITLE (PROVISIONAL)
PEER REVIEW HISTORY BMJ Paediatrics Open publishes all reviews undertaken for accepted manuscripts. Reviewers are asked to complete a checklist review form and are provided with free text boxes to elaborate
More informationExercise Prescription in Type 1 Diabetes
Exercise Prescription in Type 1 Diabetes Michael Riddell, PhD Professor, Muscle Health Research Centre and School of Kinesiology & Health Science, York University Senior Scientist, LMC Diabetes & Endocrinology,
More informationCritical Review: Is Group Therapy an Effective Intervention Method for Improving Fluency in School-Aged Children and Adolescents who Stutter?
Critical Review: Is Group Therapy an Effective Intervention Method for Improving Fluency in School-Aged Children and Adolescents who Stutter? Laura Dickson M.Cl.Sc. (SLP) Candidate University of Western
More informationT1D Exchange Clinic Registry: 25,000 strong! What is it and what have we learned to date? Georgeanna J Klingensmith, MD Barbara Davis Center
T1D Exchange Clinic Registry: 25,000 strong! What is it and what have we learned to date? Georgeanna J Klingensmith, MD Barbara Davis Center T1D Exchange Mission and Goals Improve outcomes of people touched
More informationMonitoring Protocol for Clozapine-induced Myocarditis. Copyright 2017, CAMH
1 Monitoring Protocol for Clozapine-induced Myocarditis 1 Agenda Problem Identification / Identification Importance / Importance Baseline Workflow Baseline Workflow Baseline Data Baseline Data Objectives
More informationHIV Pre- Exposure Prophylaxis
HIV Pre- Exposure Prophylaxis KNOWLEDGE AND ATTITUDES IN NORTH QUEENSLAND GENERAL PRACTITIONERS Principle Investigator: William Lane Co-Supervisor 1: Professor Clare Heal Co-Supervisor 2: Dr Jennifer Banks
More informationSpeaker Notes: Qualitative Methods in Dissemination and Implementation Research
Speaker Notes: Qualitative Methods in Dissemination and Implementation Research PART 3: DISSEMINATION CASE STUDY Slide 1: Dissemination Case Study Welcome to Qualitative Methods in Dissemination and Implementation
More informationSupporting Effective PrEP Pill Taking and Providing HIV Risk Reduction Counselling.
Supporting Effective PrEP Pill Taking and Providing HIV Risk Reduction Counselling bbrown@anovahealth.co.za Outline 1. Integrating PrEP into standard HIV risk reduction practices 2. Strategies to Support
More informationUpdates in Diabetes Technology
Updates in Diabetes Technology Jessica Kirk, MSN, RN, CPN, CDE Nurse Manager, Endo ECHO No disclosures Disclosures 1 Objectives Distinguish patients appropriate for continuous glucose monitoring and insulin
More informationLessons Learned from HPV Vaccine Study Among Young Adult Women and Men
Lessons Learned from HPV Vaccine Study Among Young Adult Women and Men Natalie Joseph, MD, MPH Assistant Professor of Pediatrics/Adolescent Medicine Boston University Medical Center Racial and ethnic differences
More informationPUTTING TECHNOLOGY INTO PRACTICE IN THE NHS
PUTTING TECHNOLOGY INTO PRACTICE IN THE NHS Dr Sufyan Hussain MA MB BChir MRCP PhD Locum Consultant Physician in Diabetes and Endocrinology Guy s and St Thomas NHS Foundation Trust On behalf of ABCD DTN-UK
More informationQUESTION 4. WHAT CLINICAL DATA ARE CURRENTLY AVAILABLE TO SUPPORT EXPANDED CGM COVERAGE BY PAYERS AS PERTAINS TO QUESTIONS 1 AND 3?
500 1 QUESTION 4. WHAT CLINICAL DATA ARE CURRENTLY AVAILABLE TO SUPPORT EXPANDED CGM COVERAGE BY PAYERS AS PERTAINS TO QUESTIONS 1 AND 3? WHAT ADDITIONAL DATA ARE NEEDED? AACE/ACE CGM Consensus Conference:
More informationTitle Page. Title Behavioral Influences on Controller Inhaler Use for Persistent Asthma in a Patient-Centered Medical Home
Title Page Title Behavioral Influences on Controller Inhaler Use for Persistent Asthma in a Patient-Centered Medical Home Authors Sue J. Lee a, Kathleen J. Pincus a, PharmD, BCPS, Adrienne A. Williams,
More informationDemographic and Health Profile. Ethiopia. Nigeria. Population is currently 73 million, annual growth rate is 2.4%
Adebola Adedimeji Demographic and Health Profile Nigeria Population is currently 150 million, annual growth rate is 2% Political structure- Federal Republic; 36 states, almost 800 local governments Multi-ethnic,
More informationInitiation of insulin adjustment for carbohydrate at onset of diabetes in children using a home-based education programme with a bolus calculator
Initiation of insulin adjustment for carbohydrate at onset of diabetes in children using a home-based education programme with a bolus calculator H Thom 1 BSc (Hons), Paediatric Diabetes Dietitian S Greene
More informationThe role of the health system in uptake of the Human Papilloma-virus (HPV) vaccine among adolescents 9-15 years in Mbale district, Eastern Uganda
The role of the health system in uptake of the Human Papilloma-virus (HPV) vaccine among adolescents 9-15 years in Mbale district, Eastern Uganda Juliet Nabirye Makerere University School of Public Health,
More informationBRIEF ACTION PLANNING. 18 Mar , 2014, 2015
BRIEF ACTION PLANNING www.centrecmi.ca 18 Mar 2015 2013, 2014, 2015 SESSION OVERVIEW Quick review of what helps support behavioral change for patients Explore the Spirit of MI Review of BAP Mr. Jones and
More informationApproaches to Understanding the End User for Microbicide Introduction. Creating Desire for Microbicides Meeting May 2014
Approaches to Understanding the End User for Microbicide Introduction Creating Desire for Microbicides Meeting May 2014 Bottleneck analysis: assess introduction challenges, even at early stages of product
More informationTelemedicine for the Care of Youth with Type 1 Diabetes
Telemedicine for the Care of Youth with Type 1 Diabetes R. Paul Wadwa, MD Associate Professor of Pediatrics Director of Telemedicine Medical Director, Pediatric Division Barbara Davis Center for Childhood
More informationImpact of insulin pumps on glycaemic control in a pump-naïve paediatric regional populationjpc_
doi:10.1111/j.1440-1754.2011.02245.x ORIGINAL ARTICLE Impact of insulin pumps on glycaemic control in a pump-naïve paediatric regional populationjpc_2245 247..252 Martin de Bock, 1 Alistair Jan Gunn, 1,2
More informationPOSITION STATEMENT. May Early diagnosis of children with Type 1 diabetes. Key points
POSITION STATEMENT Title Date Early diagnosis of children with Type 1 diabetes May 2015 Key points Early diagnosis of Type 1 diabetes is essential to allow treatment to start as soon as possible. The classic
More information